Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue

Analytical Biochemistry

Volumn 433, Issue 2, 2013, Pages 112-120

  Bruggink, Kim A ^a   Jongbloed, Wesley ^b   Biemans, Elisanne A L M ^a   Veerhuis, Rob ^b   Claassen, Jurgen A H R ^c   Kuiperij, H Bea ^a   Verbeek, Marcel M ^a  

^a RADBOUD UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Amyloid ; Brain tissue; CSF; ELISA; Heterophilic antibodies; Oligomers

Indexed keywords

ANTIBODIES; BIOMARKERS; BRAIN; CHEMICAL DETECTION; GLYCOPROTEINS; MAMMALS; NEURODEGENERATIVE DISEASES; OLIGOMERS; TISSUE;

ALZHEIMER'S DISEASE; BRAIN TISSUE; CEREBRO SPINAL FLUIDS; ELISA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN BODY FLUIDS; NEUROTOXIC SPECIES; TRANSGENIC MICE;

CEREBROSPINAL FLUID;

AMYLOID BETA PROTEIN; HETEROPHILE ANTIBODY; OLIGOMER;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT;

MUS MUSCULUS;

EID: 84870697538     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2012.09.014     Document Type: Article

References (56)

1. N. Andreasen, and K. Blennow CSF biomarkers for mild cognitive impairment and early Alzheimer's disease Clin. Neurol. Neurosurg. 107 2005 165 173
2. M. Shoji, E. Matsubara, T. Murakami, Y. Manabe, K. Abe, M. Kanai, M. Ikeda, Y. Tomidokoro, M. Shizuka, M. Watanabe, M. Amari, K. Ishiguro, T. Kawarabayashi, Y. Harigaya, K. Okamoto, T. Nishimura, Y. Nakamura, M. Takeda, K. Urakami, Y. Adachi, K. Nakashima, H. Arai, H. Sasaki, K. Kanemaru, H. Yamanouchi, Y. Yoshida, K. Ichise, K. Tanaka, M. Hamamoto, H. Yamamoto, T. Matsubayashi, H. Yoshida, H. Toji, S. Nakamura, and S. Hirai Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group Neurobiol. Aging 23 2002 363 370
3. 42, and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies Dement. Geriatr. Cogn. Disord. 19 2005 164 170
4. R. Resende, E. Ferreiro, C. Pereira, and C. Resende de Oliveira Neurotoxic effect of oligomeric and fibrillar species of amyloid-β peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death Neuroscience 155 2008 725 737
5. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
6. S. Lesne, L. Kotilinek, and K.H. Ashe Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function Neuroscience 151 2008 745 749
7. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862
8. M. Sakono, and T. Zako Amyloid oligomers: formation and toxicity of Aβ oligomers FEBS J. 277 2010 1348 1358
9. S. Barghorn, V. Nimmrich, A. Striebinger, C. Krantz, P. Keller, B. Janson, M. Bahr, M. Schmidt, R.S. Bitner, J. Harlan, E. Barlow, U. Ebert, and H. Hillen Globular amyloid β-peptide oligomer: a homogenous and stable neuropathological protein in Alzheimer's disease J. Neurochem. 95 2005 834 847
10. H. Englund, D. Sehlin, A.S. Johansson, L.N. Nilsson, P. Gellerfors, S. Paulie, L. Lannfelt, and F.E. Pettersson Sensitive ELISA detection of amyloid-β protofibrils in biological samples J. Neurochem. 103 2007 334 345
11. M.P. Lambert, P.T. Velasco, L. Chang, K.L. Viola, S. Fernandez, P.N. Lacor, D. Khuon, Y. Gong, E.H. Bigio, P. Shaw, F.G. De Felice, G.A. Krafft, and W.L. Klein Monoclonal antibodies that target pathological assemblies of Aβ J. Neurochem. 100 2007 23 35
12. M. Lindhagen-Persson, K. Brannstrom, M. Vestling, M. Steinitz, and A. Olofsson Amyloid-β oligomer specificity mediated by the IgM isotype: implications for a specific protective mechanism exerted by endogenous auto-antibodies PLoS One 5 2010 e13928
13. M.P. Lambert, K.L. Viola, B.A. Chromy, L. Chang, T.E. Morgan, J. Yu, D.L. Venton, G.A. Krafft, C.E. Finch, and W.L. Klein Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies J. Neurochem. 79 2001 595 605
14. R. Kayed, E. Head, F. Sarsoza, T. Saing, C.W. Cotman, M. Necula, L. Margol, J. Wu, L. Breydo, J.L. Thompson, S. Rasool, T. Gurlo, P. Butler, and C.G. Glabe Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers Mol. Neurodegener. 2 2007 18
15. N. Schupf, M.X. Tang, H. Fukuyama, J. Manly, H. Andrews, P. Mehta, J. Ravetch, and R. Mayeux Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease Proc. Natl. Acad. Sci. USA 105 2008 14052 14057
16. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
17. Y. Yoshiike, R. Minai, Y. Matsuo, Y.R. Chen, T. Kimura, and A. Takashima Amyloid oligomer conformation in a group of natively folded proteins PLoS One 3 2008 e3235
18. D. Howlett, P. Cutler, S. Heales, and P. Camilleri Hemin and related porphyrins inhibit β-amyloid aggregation FEBS Lett. 417 1997 249 251
19. O.M. El-Agnaf, D.S. Mahil, B.P. Patel, and B.M. Austen Oligomerization and toxicity of β-amyloid-42 implicated in Alzheimer's disease Biochem. Biophys. Res. Commun. 273 2000 1003 1007
20. D.R. Howlett, A.E. Perry, F. Godfrey, J.E. Swatton, K.H. Jennings, C. Spitzfaden, H. Wadsworth, S.J. Wood, and R.E. Markwell Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans Biochem. J. 340 1999 283 289
21. A.K. Sian, E.R. Frears, O.M. El-Agnaf, B.P. Patel, M.F. Manca, G. Siligardi, R. Hussain, and B.M. Austen Oligomerization of β-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types Biochem. J. 349 2000 299 308
22. H. LeVine III Alzheimer's β-peptide oligomer formation at physiologic concentrations Anal. Biochem. 335 2004 81 90
23. W. Xia, T. Yang, G. Shankar, I.M. Smith, Y. Shen, D.M. Walsh, and D.J. Selkoe A specific enzyme-linked immunosorbent assay for measuring β-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease Arch. Neurol. 66 2009 190 199
24. H. Fukumoto, T. Tokuda, T. Kasai, N. Ishigami, H. Hidaka, M. Kondo, D. Allsop, and M. Nakagawa High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients FASEB J. 24 2010 2716 2726
25. A.C. Klaver, L.M. Patrias, J.M. Finke, and D.A. Loeffler Specificity and sensitivity of the Aβ oligomer ELISA J. Neurosci. Methods 195 2011 249 254
26. D. Sehlin, S. Sollvander, S. Paulie, R. Brundin, M. Ingelsson, L. Lannfelt, F.E. Pettersson, and H. Englund Interference from heterophilic antibodies in amyloid-β oligomer ELISAs J. Alzheimers Dis. 21 2010 1295 1301
27. E.B. Lee, D.M. Skovronsky, F. Abtahian, R.W. Doms, and V.M. Lee Secretion and intracellular generation of truncated Aβ in β-site amyloid-β precursor protein-cleaving enzyme expressing human neurons J. Biol. Chem. 278 2003 4458 4466
28. D.A. Bateman, J. McLaurin, and A. Chakrabartty Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding BMC Neurosci. 8 2007 29
29. 42 peptide: an unbiased search for the sequence determinants of Aβ amyloidogenesis J. Mol. Biol. 319 2002 1279 1290
30. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., C.H. Kawas, W.E. Klunk, W.J. Koroshetz, J.J. Manly, R. Mayeux, R.C. Mohs, J.C. Morris, M.N. Rossor, P. Scheltens, M.C. Carrillo, B. Thies, S. Weintraub, and C.H. Phelps The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Demen. 7 2011 263 269
31. 1-42/1-40 ratio in vitro and in vivo Neuron 17 1996 1005 1013
32. N.M. Timmer, M.K. Herbert, J.W. Kleinovink, A.J. Kiliaan, R.M. de Waal, and M.M. Verbeek Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease Neuropathol. Appl. Neurobiol. 36 2010 478 486
33. N.M. Timmer, L. van Dijk, C.E. van der Zee, A. Kiliaan, R.M. de Waal, and M.M. Verbeek Enoxaparin treatment administered at both early and late stages of amyloid beta deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels Neurobiol. Dis. 40 2010 340 347
34. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
35. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle, and L. Berg The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
36. M.M. Wilhelmus, I. Otte-Holler, P. Wesseling, R.M. de Waal, W.C. Boelens, and M.M. Verbeek Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains Neuropathol. Appl. Neurobiol. 32 2006 119 130
37. 1-40) are modulated by sulfate moieties of heparin Neurosci. Res. 66 2010 380 389
38. 1-42 uptake is determined by Aβ-aggregation state and the presence of amyloid-associated proteins Glia 58 2010 1235 1246
39. D.A. Fancy, and T. Kodadek Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light Proc. Natl. Acad. Sci. USA 96 1999 6020 6024
40. G. Bitan, A. Lomakin, and D.B. Teplow Amyloid β-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins J. Biol. Chem. 276 2001 35176 35184
41. C. Stenh, H. Englund, A. Lord, A.S. Johansson, C.G. Almeida, P. Gellerfors, P. Greengard, G.K. Gouras, L. Lannfelt, and L.N. Nilsson Amyloid-β oligomers are inefficiently measured by enzyme-linked immunosorbent assay Ann. Neurol. 58 2005 147 150
42. K.A. Bruggink, M. Muller, H.B. Kuiperij, and M.M. Verbeek Methods for analysis of amyloid-β aggregates J. Alzheimers Dis. 28 2012 735 758
43. 1-42 oligomers to fibrils Nat. Struct. Mol. Biol. 17 2010 561 567
44. F. Rahimi, A. Shanmugam, and G. Bitan Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders Curr. Alzheimer Res. 5 2008 319 341
45. D.M. Walsh, A. Lomakin, G.B. Benedek, M.M. Condron, and D.B. Teplow Amyloid β-protein fibrillogenesis: detection of a protofibrillar intermediate J. Biol. Chem. 272 1997 22364 22372
46. α) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3β pathway in Alzheimer mouse model J. Biol. Chem. 286 2011 18414 18425
47. R.M. Koffie, M. Meyer-Luehmann, T. Hashimoto, K.W. Adams, M.L. Mielke, M. Garcia-Alloza, K.D. Micheva, S.J. Smith, M.L. Kim, V.M. Lee, B.T. Hyman, and T.L. Spires-Jones Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques Proc. Natl. Acad. Sci. USA 106 2009 4012 4017
48. Z. van Helmond, K. Heesom, and S. Love Characterisation of two antibodies to oligomeric Aβ and their use in ELISAs on human brain tissue homogenates J. Neurosci. Methods 176 2009 206 212
49. G.G. Klee Human anti-mouse antibodies Arch. Pathol. Lab. Med. 124 2000 921 923
50. L.J. Kricka Human anti-animal antibody interferences in immunological assays Clin. Chem. 45 1999 942 956
51. J.M. Nam, C.S. Thaxton, and C.A. Mirkin Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins Science 301 2003 1884 1886
52. D.G. Georganopoulou, L. Chang, J.M. Nam, C.S. Thaxton, E.J. Mufson, W.L. Klein, and C.A. Mirkin Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease Proc. Natl. Acad. Sci. USA 102 2005 2273 2276
53. M. Pitschke, R. Prior, M. Haupt, and D. Riesner Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy Nat. Med. 4 1998 832 834
54. S.A. Funke, E. Birkmann, F. Henke, P. Gortz, C. Lange-Asschenfeldt, D. Riesner, and D. Willbold Single particle detection of Aβ aggregates associated with Alzheimer's disease Biochem. Biophys. Res. Commun. 364 2007 902 907
55. S.A. Funke, E. Birkmann, F. Henke, P. Gortz, C. Lange-Asschenfeldt, D. Riesner, and D. Willbold An ultrasensitive assay for diagnosis of Alzheimer's disease Rejuvenation Res. 11 2008 315 318
56. A.N. Santos, S. Torkler, D. Nowak, C. Schlittig, M. Goerdes, T. Lauber, L. Trischmann, M. Schaupp, M. Penz, F.W. Tiller, and G. Bohm Detection of amyloid-β oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer J. Alzheimers Dis. 11 2007 117 125